Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medulloblastoma | 16 | 2021 | 540 | 4.480 |
Why?
|
Cerebellar Neoplasms | 11 | 2021 | 434 | 3.570 |
Why?
|
Repressor Proteins | 11 | 2022 | 1664 | 2.140 |
Why?
|
Killer Cells, Natural | 3 | 2020 | 904 | 1.070 |
Why?
|
Brain Neoplasms | 8 | 2022 | 4849 | 0.880 |
Why?
|
Schiff Bases | 1 | 2021 | 3 | 0.820 |
Why?
|
Hedgehog Proteins | 3 | 2021 | 424 | 0.810 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2021 | 36 | 0.780 |
Why?
|
DNA End-Joining Repair | 1 | 2021 | 86 | 0.760 |
Why?
|
Radiation, Ionizing | 1 | 2021 | 187 | 0.750 |
Why?
|
Ependymoma | 2 | 2020 | 242 | 0.740 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2020 | 220 | 0.690 |
Why?
|
Patched-1 Receptor | 1 | 2019 | 48 | 0.680 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2021 | 363 | 0.680 |
Why?
|
Epigenomics | 2 | 2020 | 266 | 0.670 |
Why?
|
Enzyme Inhibitors | 4 | 2018 | 1879 | 0.660 |
Why?
|
Fluorine Radioisotopes | 1 | 2019 | 133 | 0.640 |
Why?
|
Histone Demethylases | 1 | 2018 | 144 | 0.600 |
Why?
|
Drug Monitoring | 1 | 2019 | 333 | 0.580 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2019 | 287 | 0.550 |
Why?
|
Endopeptidases | 2 | 2017 | 220 | 0.520 |
Why?
|
Valproic Acid | 4 | 2010 | 263 | 0.500 |
Why?
|
DNA Replication | 5 | 2013 | 744 | 0.490 |
Why?
|
Chromatin | 2 | 2022 | 942 | 0.490 |
Why?
|
Neovascularization, Pathologic | 1 | 2021 | 1547 | 0.470 |
Why?
|
Cell Proliferation | 8 | 2021 | 7226 | 0.470 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 905 | 0.450 |
Why?
|
Myoblasts | 2 | 2010 | 72 | 0.440 |
Why?
|
Cell Line, Tumor | 17 | 2022 | 14551 | 0.420 |
Why?
|
Cell Movement | 2 | 2019 | 2466 | 0.400 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2011 | 42 | 0.400 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2054 | 0.400 |
Why?
|
Mice, SCID | 3 | 2021 | 1869 | 0.390 |
Why?
|
DNA Topoisomerases, Type II | 2 | 2010 | 116 | 0.390 |
Why?
|
Papillomaviridae | 4 | 1999 | 624 | 0.370 |
Why?
|
DNA, Viral | 3 | 1999 | 694 | 0.360 |
Why?
|
Osteosarcoma | 3 | 2023 | 929 | 0.360 |
Why?
|
Cell Differentiation | 6 | 2012 | 4078 | 0.350 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 60 | 0.330 |
Why?
|
Pyrimidines | 1 | 2021 | 3518 | 0.330 |
Why?
|
Tretinoin | 1 | 2011 | 623 | 0.320 |
Why?
|
Neuroblastoma | 2 | 2011 | 686 | 0.320 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 205 | 0.320 |
Why?
|
Cell Cycle Proteins | 3 | 2022 | 2045 | 0.300 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2022 | 8873 | 0.290 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2017 | 589 | 0.290 |
Why?
|
Cerebellum | 1 | 2010 | 449 | 0.290 |
Why?
|
Oncogenes | 2 | 2022 | 673 | 0.290 |
Why?
|
Thiadiazoles | 3 | 2016 | 47 | 0.290 |
Why?
|
Apoptosis | 7 | 2019 | 7591 | 0.280 |
Why?
|
Histone Deacetylase Inhibitors | 5 | 2012 | 612 | 0.280 |
Why?
|
Animals | 22 | 2022 | 59536 | 0.270 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 528 | 0.270 |
Why?
|
Mice | 17 | 2022 | 34495 | 0.270 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2021 | 3821 | 0.260 |
Why?
|
Histones | 5 | 2020 | 1466 | 0.250 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2018 | 461 | 0.250 |
Why?
|
Bone Neoplasms | 3 | 2023 | 2576 | 0.240 |
Why?
|
Humans | 41 | 2023 | 261506 | 0.240 |
Why?
|
Neurons | 3 | 2010 | 2287 | 0.240 |
Why?
|
Virus Replication | 2 | 1999 | 709 | 0.240 |
Why?
|
Oncogene Proteins, Viral | 3 | 1999 | 133 | 0.240 |
Why?
|
Magnetic Resonance Imaging | 2 | 2019 | 7702 | 0.220 |
Why?
|
Disease Models, Animal | 3 | 2021 | 7222 | 0.220 |
Why?
|
Glioblastoma | 4 | 2010 | 1797 | 0.220 |
Why?
|
Mice, Transgenic | 2 | 2021 | 4143 | 0.210 |
Why?
|
Etoposide | 3 | 2010 | 870 | 0.210 |
Why?
|
Cells, Cultured | 4 | 2021 | 5637 | 0.200 |
Why?
|
DNA Ligase ATP | 1 | 2021 | 51 | 0.200 |
Why?
|
DNA Breaks, Double-Stranded | 2 | 2021 | 316 | 0.200 |
Why?
|
Child | 10 | 2022 | 29154 | 0.200 |
Why?
|
DNA-Binding Proteins | 4 | 2010 | 4821 | 0.200 |
Why?
|
Schizosaccharomyces | 1 | 2001 | 116 | 0.200 |
Why?
|
DNA, Fungal | 1 | 2001 | 127 | 0.200 |
Why?
|
Glioma | 3 | 2022 | 1963 | 0.200 |
Why?
|
Fluorescent Antibody Technique | 3 | 2010 | 1062 | 0.190 |
Why?
|
Infusions, Intraventricular | 1 | 2020 | 29 | 0.190 |
Why?
|
Fungal Proteins | 1 | 2001 | 254 | 0.190 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2021 | 164 | 0.190 |
Why?
|
RNA Splicing | 1 | 2022 | 370 | 0.180 |
Why?
|
Brain Stem Neoplasms | 1 | 2020 | 108 | 0.170 |
Why?
|
Sarcoma, Ewing | 1 | 2023 | 406 | 0.170 |
Why?
|
Ubiquitin | 2 | 2017 | 344 | 0.170 |
Why?
|
Tumor Cells, Cultured | 4 | 2019 | 5395 | 0.150 |
Why?
|
Histocompatibility Antigens | 1 | 2017 | 74 | 0.150 |
Why?
|
Interleukin-2 | 1 | 2020 | 842 | 0.150 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 2016 | 852 | 0.150 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 615 | 0.150 |
Why?
|
Benzothiazoles | 1 | 2017 | 94 | 0.150 |
Why?
|
Benzene Derivatives | 1 | 2016 | 23 | 0.150 |
Why?
|
G2 Phase Cell Cycle Checkpoints | 1 | 2016 | 76 | 0.140 |
Why?
|
Tubulin Modulators | 1 | 2016 | 65 | 0.140 |
Why?
|
Homeodomain Proteins | 2 | 2013 | 1143 | 0.140 |
Why?
|
Transplantation, Heterologous | 1 | 2019 | 1082 | 0.140 |
Why?
|
Proteasome Inhibitors | 1 | 2017 | 231 | 0.140 |
Why?
|
Stathmin | 2 | 2019 | 30 | 0.140 |
Why?
|
Stilbenes | 1 | 2016 | 86 | 0.140 |
Why?
|
Fluorine-19 Magnetic Resonance Imaging | 1 | 2016 | 6 | 0.140 |
Why?
|
Antineoplastic Agents | 6 | 2021 | 14289 | 0.140 |
Why?
|
Soft Tissue Neoplasms | 1 | 2023 | 882 | 0.140 |
Why?
|
Epigenesis, Genetic | 2 | 2020 | 1399 | 0.140 |
Why?
|
Models, Biological | 3 | 2012 | 3254 | 0.130 |
Why?
|
Tubulin | 2 | 2016 | 169 | 0.130 |
Why?
|
Cerebral Ventricle Neoplasms | 1 | 2015 | 81 | 0.130 |
Why?
|
Rhabdoid Tumor | 1 | 2015 | 110 | 0.130 |
Why?
|
Cytotoxins | 1 | 2014 | 66 | 0.120 |
Why?
|
Genes, Tumor Suppressor | 1 | 2018 | 1064 | 0.120 |
Why?
|
Methotrexate | 2 | 2015 | 999 | 0.120 |
Why?
|
Benzamides | 3 | 2009 | 1832 | 0.120 |
Why?
|
Mitosis | 1 | 2016 | 615 | 0.120 |
Why?
|
Cell Survival | 2 | 2018 | 3045 | 0.120 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 803 | 0.120 |
Why?
|
Chromosome Fragility | 1 | 2013 | 33 | 0.120 |
Why?
|
G-Quadruplexes | 1 | 2013 | 17 | 0.120 |
Why?
|
Transcription, Genetic | 2 | 2012 | 3154 | 0.110 |
Why?
|
Gene Knockdown Techniques | 2 | 2016 | 1077 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 3639 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 15862 | 0.110 |
Why?
|
Sarcoma | 1 | 2023 | 1725 | 0.110 |
Why?
|
Pyridines | 3 | 2009 | 1244 | 0.110 |
Why?
|
Mice, Knockout | 2 | 2019 | 5710 | 0.100 |
Why?
|
Viral Proteins | 1 | 1994 | 435 | 0.100 |
Why?
|
DNA Methylation | 2 | 2020 | 2669 | 0.100 |
Why?
|
Protein Stability | 1 | 2012 | 370 | 0.100 |
Why?
|
Clinical Decision-Making | 1 | 2015 | 524 | 0.100 |
Why?
|
Contactin 2 | 1 | 2010 | 8 | 0.100 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2012 | 611 | 0.100 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2012 | 280 | 0.100 |
Why?
|
Indoles | 1 | 2016 | 1009 | 0.090 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2011 | 154 | 0.090 |
Why?
|
Proteolysis | 1 | 2012 | 370 | 0.090 |
Why?
|
Base Sequence | 4 | 2022 | 4917 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 2864 | 0.090 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 305 | 0.090 |
Why?
|
Histone Deacetylases | 1 | 2012 | 365 | 0.090 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2014 | 566 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 1493 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2016 | 5178 | 0.090 |
Why?
|
Neurogenesis | 1 | 2012 | 238 | 0.090 |
Why?
|
Hydroxamic Acids | 1 | 2012 | 442 | 0.090 |
Why?
|
Binding Sites | 3 | 2022 | 2171 | 0.090 |
Why?
|
Adolescent | 5 | 2020 | 31252 | 0.090 |
Why?
|
Fas-Associated Death Domain Protein | 1 | 2009 | 25 | 0.090 |
Why?
|
Transcription Factors | 4 | 2022 | 5270 | 0.090 |
Why?
|
Choroid Plexus | 1 | 2008 | 31 | 0.080 |
Why?
|
Caspase 8 | 1 | 2009 | 145 | 0.080 |
Why?
|
Imidazoles | 1 | 2014 | 999 | 0.080 |
Why?
|
HeLa Cells | 3 | 2017 | 1643 | 0.080 |
Why?
|
In Situ Nick-End Labeling | 1 | 2009 | 448 | 0.080 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2010 | 287 | 0.080 |
Why?
|
Calcium-Binding Proteins | 1 | 2010 | 545 | 0.080 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 6942 | 0.080 |
Why?
|
Replication Origin | 2 | 1999 | 21 | 0.080 |
Why?
|
Drug Synergism | 2 | 2010 | 1313 | 0.080 |
Why?
|
Translocation, Genetic | 1 | 2013 | 1245 | 0.080 |
Why?
|
Prognosis | 2 | 2018 | 21713 | 0.080 |
Why?
|
Immunoprecipitation | 1 | 2009 | 591 | 0.080 |
Why?
|
Lysine | 2 | 2020 | 422 | 0.070 |
Why?
|
Female | 9 | 2020 | 141928 | 0.070 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 622 | 0.070 |
Why?
|
Plasmids | 3 | 1999 | 837 | 0.070 |
Why?
|
MicroRNAs | 1 | 2020 | 2947 | 0.070 |
Why?
|
Animals, Newborn | 1 | 2010 | 1338 | 0.070 |
Why?
|
Gene Expression | 3 | 2013 | 3570 | 0.070 |
Why?
|
Immunotherapy, Adoptive | 1 | 2016 | 1763 | 0.070 |
Why?
|
Astrocytoma | 1 | 2008 | 321 | 0.070 |
Why?
|
Male | 6 | 2020 | 123000 | 0.070 |
Why?
|
Signal Transduction | 3 | 2019 | 11965 | 0.070 |
Why?
|
Infant | 2 | 2019 | 13310 | 0.060 |
Why?
|
Isoenzymes | 1 | 2007 | 614 | 0.060 |
Why?
|
Child, Preschool | 5 | 2015 | 16273 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 1265 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 10035 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 3719 | 0.060 |
Why?
|
Genes, myc | 1 | 2006 | 358 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 2488 | 0.060 |
Why?
|
Molecular Structure | 2 | 2016 | 515 | 0.060 |
Why?
|
K562 Cells | 2 | 2016 | 338 | 0.060 |
Why?
|
Mice, Inbred BALB C | 2 | 2020 | 2314 | 0.060 |
Why?
|
CD27 Ligand | 1 | 2023 | 25 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2023 | 11538 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2019 | 13658 | 0.060 |
Why?
|
Immune Evasion | 1 | 2023 | 73 | 0.060 |
Why?
|
Molecular Sequence Data | 3 | 2013 | 6089 | 0.060 |
Why?
|
Acetylation | 2 | 2018 | 508 | 0.060 |
Why?
|
Blotting, Western | 1 | 2009 | 3536 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2009 | 3033 | 0.050 |
Why?
|
Phosphorylation | 2 | 2019 | 4804 | 0.050 |
Why?
|
Receptors, Notch | 2 | 2018 | 383 | 0.050 |
Why?
|
Spliceosomes | 1 | 2022 | 75 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2001 | 329 | 0.050 |
Why?
|
Neurofibromin 1 | 1 | 2022 | 85 | 0.050 |
Why?
|
Schizosaccharomyces pombe Proteins | 1 | 2001 | 84 | 0.050 |
Why?
|
Subcellular Fractions | 1 | 2001 | 201 | 0.050 |
Why?
|
Cell Line, Transformed | 2 | 2008 | 394 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2014 | 4938 | 0.050 |
Why?
|
Adult | 5 | 2022 | 77950 | 0.050 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2023 | 406 | 0.050 |
Why?
|
Genes, Neoplasm | 1 | 2022 | 324 | 0.050 |
Why?
|
Mice, Inbred C3H | 1 | 2020 | 385 | 0.050 |
Why?
|
Sequence Analysis, RNA | 1 | 2023 | 651 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2010 | 7548 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2022 | 842 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 2 | 2010 | 289 | 0.040 |
Why?
|
Stem Cells | 1 | 2006 | 1213 | 0.040 |
Why?
|
Cell Line | 3 | 2014 | 5114 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2022 | 584 | 0.040 |
Why?
|
Protein Interaction Maps | 1 | 2019 | 149 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2018 | 125 | 0.040 |
Why?
|
Exons | 1 | 2022 | 1328 | 0.040 |
Why?
|
MAP Kinase Signaling System | 1 | 2022 | 848 | 0.040 |
Why?
|
Sirtuin 1 | 1 | 2018 | 89 | 0.040 |
Why?
|
ras Proteins | 1 | 2022 | 770 | 0.040 |
Why?
|
Polymerization | 1 | 2016 | 17 | 0.040 |
Why?
|
Cell Cycle | 2 | 2014 | 2084 | 0.040 |
Why?
|
Biophysical Phenomena | 1 | 2016 | 112 | 0.040 |
Why?
|
A549 Cells | 1 | 2016 | 124 | 0.040 |
Why?
|
Thymidine | 1 | 1995 | 155 | 0.030 |
Why?
|
Methyltransferases | 1 | 2017 | 148 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 336 | 0.030 |
Why?
|
DNA (Cytosine-5-)-Methyltransferases | 1 | 2018 | 310 | 0.030 |
Why?
|
Cell Cycle Checkpoints | 1 | 2017 | 278 | 0.030 |
Why?
|
Methylation | 1 | 2017 | 597 | 0.030 |
Why?
|
Fourth Ventricle | 1 | 2015 | 51 | 0.030 |
Why?
|
Genes, ras | 1 | 2018 | 667 | 0.030 |
Why?
|
Bovine papillomavirus 1 | 1 | 1994 | 8 | 0.030 |
Why?
|
Protein Domains | 1 | 2016 | 314 | 0.030 |
Why?
|
Cell Count | 1 | 2016 | 508 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1987 | 0.030 |
Why?
|
Transcriptome | 1 | 2023 | 1859 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1994 | 354 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2016 | 875 | 0.030 |
Why?
|
GC Rich Sequence | 1 | 2013 | 7 | 0.030 |
Why?
|
Neoplasms | 2 | 2017 | 15193 | 0.030 |
Why?
|
Drug Design | 1 | 2016 | 375 | 0.030 |
Why?
|
Chromosome Fragile Sites | 1 | 2013 | 38 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 1999 | 1555 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2013 | 104 | 0.030 |
Why?
|
DNA, Single-Stranded | 1 | 2013 | 106 | 0.030 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2013 | 135 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2016 | 750 | 0.030 |
Why?
|
Up-Regulation | 1 | 2019 | 2450 | 0.030 |
Why?
|
Adenine | 1 | 1995 | 631 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2014 | 931 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 987 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2016 | 1489 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2013 | 272 | 0.030 |
Why?
|
Spinal Cord | 1 | 2015 | 690 | 0.030 |
Why?
|
Models, Molecular | 1 | 2016 | 1732 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2013 | 694 | 0.020 |
Why?
|
Cyclic S-Oxides | 1 | 2010 | 12 | 0.020 |
Why?
|
Mutation | 2 | 2022 | 15179 | 0.020 |
Why?
|
Transcription Factor HES-1 | 1 | 2010 | 49 | 0.020 |
Why?
|
Veratrum Alkaloids | 1 | 2010 | 32 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3981 | 0.020 |
Why?
|
U937 Cells | 1 | 2010 | 171 | 0.020 |
Why?
|
Carcinogenesis | 1 | 2017 | 1026 | 0.020 |
Why?
|
Zinc Finger Protein GLI1 | 1 | 2010 | 111 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2010 | 518 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 9180 | 0.020 |
Why?
|
DNA Damage | 1 | 2017 | 1954 | 0.020 |
Why?
|
Tetrazolium Salts | 1 | 2008 | 54 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2010 | 503 | 0.020 |
Why?
|
Antigens, Viral, Tumor | 1 | 2008 | 47 | 0.020 |
Why?
|
Pilot Projects | 1 | 2015 | 2803 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2020 | 3869 | 0.020 |
Why?
|
Uterine Cervical Neoplasms | 2 | 1999 | 1833 | 0.020 |
Why?
|
Gamma Rays | 1 | 2008 | 242 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2008 | 726 | 0.020 |
Why?
|
Mathematical Computing | 1 | 2006 | 22 | 0.020 |
Why?
|
Carcinogenicity Tests | 1 | 2006 | 70 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2006 | 342 | 0.020 |
Why?
|
Kidney | 1 | 1994 | 2146 | 0.020 |
Why?
|
Doxycycline | 1 | 2006 | 178 | 0.020 |
Why?
|
Muscle Cells | 1 | 2004 | 38 | 0.020 |
Why?
|
Thiazoles | 1 | 2008 | 726 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 2390 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 2927 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 32848 | 0.010 |
Why?
|
Insecta | 1 | 1999 | 76 | 0.010 |
Why?
|
Mice, Nude | 1 | 2006 | 4307 | 0.010 |
Why?
|
Carcinoma | 1 | 2008 | 2578 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 21445 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2008 | 10001 | 0.010 |
Why?
|
Models, Genetic | 1 | 1999 | 1113 | 0.010 |
Why?
|
Transfection | 1 | 1999 | 2944 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2008 | 37905 | 0.000 |
Why?
|